MetaCap

Blackbaud (BLKB) vs Cellebrite DI (CLBT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Blackbaud (BLKB) has outperformed Cellebrite DI (CLBT) over the past year, losing 13.6% versus a loss of 36.2%. Over five years, CLBT leads with a +24.1% price change compared with -37.0% for BLKB. Cellebrite DI is the larger company by market cap ($2.71 billion vs $2.20 billion), about 1.2 times the size.

On valuation, Blackbaud trades at a lower forward P/E (8.1x vs 16.1x for Cellebrite DI). Cellebrite DI converts more of its revenue into profit, with a net margin of 16.5% versus 10.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BLKB-13.56%CLBT-36.20%
+17%-20%-56%
Nov 21, 20251 yearNov 20, 2026
BLKB-41.10%CLBT+16.31%
+186%+54%-79%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BLKB versus CLBT key metrics
MetricBLKBCLBT
Share price$48.83$10.77
Market cap$2.20B$2.71B
1-day change-0.39%-4.86%
YTD return-22.88%-40.27%
1-year return-13.56%-36.20%
5-year return-37.00%+24.08%
P/E ratio (TTM)15.0243.08
Forward P/E8.1416.09
EPS (TTM)$3.25$0.25
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$1.13B$475.68M
Revenue growth (YoY)-2.27%+18.56%
Net income (latest FY)$114.97M$78.33M
Gross margin58.78%84.20%
Operating margin16.91%13.98%
Net margin10.19%16.47%
52-week high$64.84$19.39
52-week low$25.58$9.58
Distance from 52-week high-24.69%-44.46%
Analyst consensusnonestrong_buy
Avg. price target upside+15.20%+43.27%
Average volume421.21K2.35M
Shares outstanding44.98M251.34M
Employees2,8001,285
SectorTechnologyTechnology
IndustryComputer Software: Prepackaged SoftwareComputer Software: Prepackaged Software

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BLKB has outperformed CLBT by 22.6 percentage points over the past year.
  • Cellebrite DI trades at a higher earnings multiple (43.1x vs 15.0x trailing P/E).
  • Cellebrite DI is more profitable, keeping 16.5 cents of every revenue dollar as net income versus 10.2 cents for Blackbaud.
  • Cellebrite DI grew revenue faster in its latest fiscal year (+18.56% vs -2.27%).

About Blackbaud

BLKB stock →

Blackbaud, Inc. engages in the providing AI-powered solutions in the United States and internationally.

Technology · Computer Software: Prepackaged Software · 2,800 employees

About Cellebrite DI

CLBT stock →

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Technology · Computer Software: Prepackaged Software · 1,285 employees

BLKB vs CLBT FAQ

Which is bigger, Blackbaud or Cellebrite DI?

Cellebrite DI (CLBT) is larger, with a market capitalization of $2.71B compared with $2.20B for Blackbaud (BLKB).

Which stock has performed better over the past year, BLKB or CLBT?

BLKB returned -13.56% over the past 12 months, compared with -36.20% for CLBT (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, BLKB or CLBT?

BLKB has the lower trailing P/E at 15.0, versus 43.1 for CLBT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Blackbaud and Cellebrite DI in the same industry?

Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.

More comparisons